ASX:NSB NeuroScientific Biopharmaceuticals (NSB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About NeuroScientific Biopharmaceuticals Stock (ASX:NSB) 30 days 90 days 365 days Advanced Chart Get NSB alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationA$5.64 millionP/E Ratio17.39Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Biopharmaceuticals Read More Receive NSB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroScientific Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address NSB Stock News HeadlinesNeuroScientific Biopharmaceuticals Director Increases ShareholdingJuly 1, 2025 | tipranks.comWe're Hopeful That NeuroScientific Biopharmaceuticals (ASX:NSB) Will Use Its Cash WiselyMay 20, 2022 | finance.yahoo.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.July 12 at 2:00 AM | Porter & Company (Ad)We Think NeuroScientific Biopharmaceuticals (ASX:NSB) Needs To Drive Business Growth CarefullyMay 20, 2022 | finance.yahoo.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryBanking Current SymbolASX:NSB CIKN/A Webwww.neuroscientific.com Phone61 8 6382 1800FaxN/AEmployees283Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio17.39 Forward P/E RatioN/A P/E GrowthN/ANet Income-A$1.07 million Net Margins14.66% Pretax MarginN/A Return on Equity7.08% Return on Assets1.81% Debt Debt-to-Equity RatioN/A Current Ratio58.87 Quick Ratio3.31 Sales & Book Value Annual SalesA$2.21 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.04 per share Price / BookN/AMiscellaneous Outstanding Shares144,600,000Free FloatN/AMarket CapA$5.64 million OptionableNot Optionable Beta0.57 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (ASX:NSB) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroScientific Biopharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroScientific Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NSB Stock Alerts